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SUMMARY
Small RNAs target invaders for silencing in the CRISPR-Cas pathways that protect bacteria and
archaea from viruses and plasmids. The CRISPR RNAs (crRNAs) contain sequence elements
acquired from invaders that guide CRISPR-associated (Cas) proteins back to the complementary
invading DNA or RNA. Here, we have analyzed essential features of the crRNAs associated with
the Cas RAMP module (Cmr) effector complex, which cleaves targeted RNAs. We show that Cmr
crRNAs contain an 8-nucleotide 5’ sequence tag (also found on crRNAs associated with other
CRISPR-Cas pathways) that is critical for crRNA function and can be used to engineer crRNAs
that direct cleavage of novel targets. We also present data that indicates that the Cmr complex
cleaves an endogenous complementary RNA in Pyrococcus furiosus, providing direct in vivo
evidence of RNA targeting by the CRISPR-Cas system. Our findings indicate that the CRISPR
RNA-Cmr protein pathway may be exploited to cleave RNAs of interest.

INTRODUCTION
NIH-PA Author Manuscript

The CRISPR-Cas systems are RNA-based immune systems that protect prokaryotes from
viruses, plasmids, and other invaders (see recent general reviews: (Deveau et al., 2010;
Horvath and Barrangou, 2010; Jore et al., 2011a; Karginov and Hannon, 2010; Makarova et
al., 2011; Marraffini and Sontheimer, 2010; Terns and Terns, 2011; van der Oost et al.,
2009)). The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) loci found
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in prokaryotic genomes acquire short fragments of invader sequence (~30-40 base pairs in
length) that are inserted between short CRISPR repeat sequences. The CRISPR loci give rise
to CRISPR RNAs (crRNAs) that each contain an invader-derived (guide) sequence and
interact with CRISPR-associated or Cas proteins to form effector complexes that recognize
and silence the corresponding invader (Brouns et al., 2008; Hale et al., 2008; Hale et al.,
2009; Jore et al., 2011b; Lintner et al., 2011; Wiedenheft et al., 2011). There are multiple
modules of Cas proteins (termed for example Cse and Csy proteins) that can function
independently with crRNAs to effect CRISPR-Cas defense (Haft et al., 2005; Makarova et
al., 2006; Makarova et al., 2011; Terns and Terns, 2011); thus distinct CRISPR-Cas
pathways function in various prokaryotes.
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CRISPR-Cas-mediated silencing appears to occur through sequence-specific targeting of
RNA or DNA. In Streptococcus thermophilus (Barrangou et al., 2007; Garneau et al., 2010),
Escherichia coli (Brouns et al., 2008; Semenova et al., 2011), Staphylococcus epidermidis
(Marraffini and Sontheimer, 2008), and Sulfolobus solfataricus (Gudbergsdottir et al., 2011;
Manica et al., 2011), there is evidence that CRISPR-Cas systems target foreign DNA.
Indeed, sequence-specific cleavage of both plasmid and bacteriophage DNA was recently
documented in S. thermophilus (Garneau et al., 2010). At the same time, the Cmr-type
crRNA-Cas protein complex from Pyrococcus furiosus specifically cleaves complementary
RNAs (Hale et al., 2009). Thus, the various CRISPR-Cas systems (formed by distinct
modules of Cas proteins) may function by different mechanisms, including DNA and RNA
cleavage. Interestingly, many organisms possess more than one module of Cas proteins and
may resist invaders by multiple mechanisms to provide robust protection from diverse
invaders.
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CRISPR RNAs (previously also referred to as prokaryotic silencing (psi)RNAs) are utilized
by all versions of the CRISPR-Cas system characterized to date (Brouns et al., 2008;
Deltcheva et al., 2011; Gudbergsdottir et al., 2011; Hale et al., 2009; Lintner et al., 2011;
Manica et al., 2011; Marraffini and Sontheimer, 2008; Wiedenheft et al., 2011). The
CRISPR loci are transcribed from a leader sequence region of 100-500 basepairs found at
one end of each locus (Jansen et al., 2002), where promoter sequences have been identified
in a few organisms (Lillestol et al., 2009; Pul et al., 2010). Insertion of new invader-derived
sequences into CRISPR loci most frequently occurs immediately downstream of the leader
(Andersson and Banfield, 2008; Barrangou et al., 2007; Pourcel et al., 2005; Shah et al.,
2009). The CRISPR locus transcripts are cleaved within the repeat sequence to release the
individual embedded crRNAs. A series of structurally related proteins from various
CRISPR-Cas systems process CRISPR RNA transcripts: Cas6 (Carte et al., 2010; Carte et
al., 2008; Wang et al., 2011), Cse3 (Brouns et al., 2008; Gesner et al., 2011; Sashital et al.,
2011), and Csy4 (Haurwitz et al., 2010; Przybilski et al., 2011). Cleavage within the repeats
by these Cas endonucleases produces 1X intermediate RNAs generally comprised of 8
nucleotides of repeat sequence (called the 5’ tag), a guide sequence, and the remaining
~20-25 nucleotides (nt) of repeat sequence at the 3’ end (the 3’ tag) (Brouns et al., 2008;
Gesner et al., 2011; Hale et al., 2008; Haurwitz et al., 2010). These 1X intermediates
undergo various amounts of 3’ end trimming (Hale et al., 2008; Hale et al., 2009; Jore et al.,
2011b; Lintner et al., 2011; Marraffini and Sontheimer, 2008; Wiedenheft et al., 2011).
However, an equivalent 8-nt 5’ tag is present on mature crRNAs from a variety of bacterial
and archaeal species including E. coli (Brouns et al., 2008), S. epidermidis (Marraffini and
Sontheimer, 2008), Pseudomonas aeruginosa (Haurwitz et al., 2010), P. furiosus (Hale et
al., 2008; Hale et al., 2009), S. solfataricus ((Lintner et al., 2011), our unpublished data),
Sulfolobus tokadai (our unpublished data), and Thermococcus kodakarensis (our
unpublished data). In S. epidermis, the 5’ tag of the crRNAs provides for discrimination
between self (i.e., the complementary DNA strand in the CRISPR locus, which can basepair
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with the tag) and non-self (invader DNA, which does not basepair with the tag) (Marraffini
and Sontheimer, 2010), but other functions of this crRNA signature sequence are not known.
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There are 3 modules of Cas proteins (Cmr, Csa, and Cst) and 7 CRISPR loci encoded in the
genome of the hyperthermophilic archaeon P. furiosus. Previously, we identified and
characterized a complex comprised of the Cas module RAMP or Cmr proteins (Cmr1-6) and
2 crRNA species in P. furiosus (Hale et al., 2009). The Cmr-crRNA protein complex is
unique among CRISPR-Cas systems characterized to date in that it targets RNA; the
complex specifically cleaves RNAs that are complementary to the crRNAs, 14 nt from the
3’ end of the crRNAs (Hale et al., 2009). Activity was observed in vitro using both native
and reconstituted complexes, but has not been described in vivo. Here we have investigated
the functionality of the crRNAs that direct cleavage by the Cmr complex. Deep sequencing
of the RNAs associated with the complex as well as total crRNAs unexpectedly revealed the
cleavage of a fortuitous endogenous target RNA by the Cmr complex in vivo. While
multiple species of crRNAs are present in P. furiosus, the Cmr complex selectively includes
45- and 39-nt crRNAs regardless of the size of the invader-derived guide sequence encoded
in the genome. We show that the 8-nt 5’ tag sequence is not only necessary for Cmr-directed
cleavage, but can be used to target the complex to cleave novel RNAs, providing the
potential for manipulation of the CRISPR-Cas system for experimental or pharmaceutical
gene silencing.
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RESULTS
Key features of the Cmr complex RNAs
To delineate functional features of the crRNAs that guide cleavage by the Cmr complex, we
isolated active Cmr complexes using antibodies against the Cmr2 protein. Polyclonal
antibodies raised against recombinant P. furiosus Cmr2 specifically immunoprecipitated
Cmr2 (assessed by Western blotting, Figure 1A), as well as the five other Cmr complex
proteins (Cmr1 and Cmr3-6; assessed by mass spectrometry, unpublished data), and 39- and
45-nt species of a crRNA (assessed by Northern blotting, Figure 1B). Moreover, the
immunoprecipitated RNA-protein complex replicated the cleavage activity observed with
both the chromatographically-purified and reconstituted Cmr complexes (Hale et al., 2009),
cleaving a target RNA (complementary to one of the endogenous crRNAs) at the two sites
located 14 nt upstream of the 3’ ends of the complementary 39- and 45-nt crRNA species
(Figure 1C).
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We probed the nature of the end groups of the crRNAs immunopurified with Cmr
complexes by end radiolabeling. 5’ end labeling of the 39- and 45-nt RNAs was not affected
by prior enzymatic treatment with phosphatase, whereas phosphatase pre-treatment
significantly increased 3’ end labeling of the RNAs (Figure 1D), indicating that the majority
of both species of crRNAs in the Cmr complex contain 5’ hydroxyl and 3’ phosphate end
groups.
In order to further characterize the Cmr-associated crRNAs, we deep-sequenced the RNAs
immunopurified with the complex, as well as total P. furiosus small RNAs. We isolated
RNAs smaller than ~70 nt by gel purification, and based on the results of end group analysis
(Figure 1D), treated the RNAs with phosphatase to optimize cloning. The cDNA libraries
were subject to Illumina sequencing. Figure 2A shows the numbers of small RNA sequence
reads that map to each of the seven P. furiosus CRISPR loci from the total RNA and Cmr
complex samples. A total of 2,632,773 uniquely mapped small RNA reads were obtained
from the total RNA sample, of which 54.5% mapped to the CRISPR loci. In contrast, 91.2%
of the 990,060 uniquely mapped reads from the Cmr complex sample mapped to the
CRISPR loci.
Mol Cell. Author manuscript; available in PMC 2013 February 10.
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The total RNA profiles indicate that RNAs are expressed from all seven P. furiosus CRISPR
loci (Figure 2A, total RNA) as limited sequencing data had previously suggested (Hale et
al., 2009). We analyzed the leader sequences of the seven CRISPR loci and found canonical
BRE/TATA promoter sequences at a conserved position within the leaders (Figure 2B). A
population of RNAs was detected that begins ~21 nt downstream of these promoter elements
(and includes ~29 nt of the leader sequence at the 5’ end, indicated in red in Figure 2B).
(These RNAs do not represent the major crRNA species, which are described below.) These
findings suggest that the CRISPR loci are transcribed by archaeal RNA polymerase via
recognition of the BRE/TATA promoters within the leader sequences. The deep sequencing
data also indicate that, in general, crRNAs from the leader-proximal regions of the CRISPR
loci are more abundant than crRNAs encoded downstream, as had been hypothesized based
on previous data (Hale et al., 2008). The molecular basis for the gradient in steady state
levels of the crRNAs from each locus is currently unknown, but could reflect differences in
transcription, processing, or stability. The expression gradient is noteworthy because the
crRNAs that arise from the leader-proximal end of a CRISPR locus generally target the most
recent invaders confronted by the system (Andersson and Banfield, 2008; Barrangou et al.,
2007; Pourcel et al., 2005; Shah et al., 2009)
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Deep sequencing and Northern analysis indicate that a series of species of crRNAs of
different lengths are present in P. furiosus, and that the Cmr complex specifically loads two
of these crRNA species. The 5’ ends of the vast majority of crRNAs in P. furiosus, in both
the total and Cmr complex samples, are comprised of an identical 5’ end tag sequence
(AUUGAAAG) derived from the upstream repeat element (Figure 3A). This end is
generated by Cas6 cleavage of CRISPR transcripts at this site (Carte et al., 2010; Carte et
al., 2008; Wang et al., 2011). In total RNA, a mixture of 3’ ends corresponding to crRNAs
30 to 70 nt in length is observed (Figure 3A), consistent with a series of RNA species
detected in total RNA by Northern analysis of one of the crRNAs (Figure 1B, T lane).
Strikingly, the 39- and 45-nt crRNA species selectively co-purify with the Cmr complex
(Figures 1B and 3A). The 45-nt crRNAs constitute 46% of the crRNAs associated with the
Cmr complex, and the 39-nucleotide species make up 38% (Figure 3A).
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Interestingly, the deep sequence analysis indicates that the 3’ ends of the Cmr complexassociated crRNAs are defined by distance from the 5’ tag or absolute length of the crRNA
(rather than, for example, by the length of the guide sequence encoded in the CRISPR locus
or by position relative to the 3’ repeat element). Guide sequences in P. furiosus CRISPRs
are most commonly 37 nt long, in which case the 45-nt crRNA species is comprised of an 8nt repeat tag sequence and a full 37-nt guide sequence. (The 39-nt species simply lacks 6 nt
of the guide sequence at the 3’ end, see Figure 3A.) However some guide sequences are as
short as 34 nt and as long as 59 nt in P. furiosus, and Cmr complex crRNAs are nonetheless
consistently 39 and 45 nt in length. For example, while three of the first 5 guide sequences
in CRISPR locus 4 are 37 nt long, the second guide sequence in the locus (termed 4.02) is
35 nt; yet the 4.02 crRNAs found in the Cmr complex are 45 and 39 nt in length (Figure
3B). The 45-nt 4.02 crRNA includes 2 nt of the downstream repeat sequence. Conversely,
the fifth CRISPR 4 guide sequence is one nt longer than standard (38 nt), and the 45-nt 4.05
crRNA lacks the last encoded nt of the guide sequence (Figure 3B). Similarly, the first guide
sequence in CRISPR 1 is 48 nt long (11 nt longer than is typical), and the 45-nt 1.01 crRNA
found in the Cmr complex includes only 37 nt of the 48-nt guide sequence (see Figure 4B).
Thus, regardless of the size of the guide sequence encoded in the genome, the crRNAs of the
Cmr complex are comprised of an 8-nt 5’ repeat tag and a 37- or 31-nt guide sequence.
Cleavage of a complementary RNA in vivo
Very few RNAs were detected that were transcribed from the opposite (non-leader) ends of
the CRISPR loci in P. furiosus; however, we did detect significant antisense transcription
Mol Cell. Author manuscript; available in PMC 2013 February 10.
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from an apparently fortuitous promoter within CRISPR locus 1. A BRE/TATA promoter
sequence is present in the antisense orientation within the second guide sequence of CRISPR
locus 1, and a significant number of antisense RNAs that begin distinctly 21 nt downstream
of the promoter are present in the sequence from the total RNA sample (Figure S1, blue
reads). The number of antisense RNA reads is approximately 1/3 the number of reads
observed for the sense strand crRNA reads (crRNA 1.01; Figure S1, red reads). Northern
analysis reveals a series of antisense RNAs up to ~140 nt in length in total P. furiosus RNA
(Figure 4A, 1.01 antisense, total (T) lane).
The antisense CRISPR transcripts found in P. furiosus would be predicted to be recognized
and targeted by Cmr complexes containing the crRNA encoded on the opposite strand of
CRISPR locus 1 (crRNA 1.01). Previous in vitro studies established that the Cmr complex
cleaves complementary RNAs 14 nt upstream of the 3’ ends of the 39- and 45-nt crRNAs
(Hale et al., 2008). Accordingly, in this case, the 1.01 crRNAs would be predicted to
generate 5’ products of 45 and 39 nt (as well as 3’ products of various lengths) upon
cleavage of the antisense transcripts. And indeed, distinct antisense RNAs of 45 and 39 nt
were observed in Northern analysis of the total RNA (with a probe to the 5’ region of the
antisense transcript; Figure 4A, 1.01 antisense, total (T) lane), suggesting that the Cmr
complex targets and cleaves the endogenous CRISPR1 antisense transcript in P. furiosus.
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We also found in both RNA sequencing and Northern analysis that the 45- and 39-nt
putative 5’ cleavage products are specifically co-immunopurified with the Cmr complex
(Figure 4A, 1.01 antisense, immune (I) vs. preimmune (PI) lanes; and Figure 4B, blue reads
vs. Figure S1, blue reads), suggesting that the products remain associated with the complex
to some extent following cleavage. The 45- and 39-nt antisense RNAs do not possess the 5’
repeat tag sequence, which we hypothesize is important for recognition and function of
crRNAs with the Cmr complex. However, because of the coincidence in the size of these
RNAs with Cmr complex crRNA species, we tested the possibility that the antisense RNAs
are functional guide RNAs. We found that the immunopurified Cmr complexes do not
cleave a target RNA complementary to the antisense RNAs, indicating that the antisense
RNAs do not guide cleavage by the Cmr complex (Figure 4C, antisense RNA target). At the
same time, the immunopurified complexes do cleave an RNA corresponding to the ~140-nt
antisense RNA transcript, generating 5’ products of the same sizes observed in vivo (45 and
39 nt; Figure 4C, crRNA target). Together, the findings indicate that the Cmr complex
recognizes and cleaves endogenous complementary RNAs in vivo.
The CRISPR repeat tag sequence is required for functional Cmr complex crRNAs
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Its conservation suggests that the 5’ CRISPR repeat tag is an important element of
functional Cmr complex crRNAs. We investigated the importance of the tag by testing
several tag sequence mutants for the ability to guide cleavage by reconstituted Cmr
complexes. Removal of the repeat tag sequence from crRNA 7.01 eliminates cleavage of a
complementary target RNA (Figure 5A). Substitution of the entire tag sequence to its
complement (AUUGAAAG → UAACUUUC) or of the first two nucleotides of the tag
sequence (AUUGAAAG → GAUGAAAG) also prevents function of the crRNA, as does
the addition of a G at the 5’ end of the tag (Figure 5B).
Analysis of CRISPR locus 8 provided further insight into the basis for the importance of the
5’ repeat tag in vivo. crRNAs from locus 8 were significantly underrepresented in the Cmr
complex (Figures 2A and S2). The reduced presence of CRISPR locus 8 RNAs in the Cmr
complex correlates with a difference in the 5’ repeat tag found on these RNAs. Most of the
crRNAs from locus 8 possess a 7-nt AUUGAAG (rather than 8-nt AUUGAAAG) repeat tag
due to a variation in the repeat sequences within this CRISPR locus (Figure 5C). The
exception is crRNA 8.11 (the last crRNA encoded by locus 8), which retains the canonical
Mol Cell. Author manuscript; available in PMC 2013 February 10.
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8-nt repeat tag sequence, and this crRNA is selectively enriched in the Cmr complex relative
to the other crRNAs from CRISPR locus 8 (Figures 2A and 5C). Together, these results
indicate that the CRISPR repeat tag is critical for the formation of functional Cmr
complexes by crRNAs.
For CRISPR-Cas systems that target DNA, the 5’ repeat tag on the crRNAs provides a key
function in distinguishing self from non-self. In organisms with these systems, it is
important for crRNAs to avoid targeting the complementary DNA sequence found in the
host CRISPR locus itself, and evidence indicates that, in these systems, potential targets
with complementarity to the tag sequence (found in the CRISPR locus but not in invader
targets) are not silenced (Marraffini and Sontheimer, 2010). We tested the effect of target
complementarity to the tag sequence on RNA cleavage by the Cmr complex, and observed
no significant reduction in activity (Figure 5D). The antisense transcript that is cleaved in
vivo by the Cmr complex also is complementary to the tag of crRNA 1.01 (Figure 4). Thus,
RNA targeting by the Cmr complex does not require a lack of complementarity between the
target and the crRNA repeat tag.
crRNAs can be engineered to direct the Cmr complex to cleave novel target RNAs
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Our findings indicate that a 5’ repeat tag is necessary for a crRNA to function to guide
cleavage by the Cmr complex. To determine whether the Cmr complex can be directed to
cleave novel target RNAs by engineered crRNAs, we designed crRNAs with the 5’
AUUGAAAG tag sequence and guide sequences complementary to a random target
sequence (X’) or to a sequence near the 5’ end of the β-lactamase (bla) mRNA. Cmr
complexes reconstituted with the crRNA designed to cleave the random target sequence
specifically cleaved the X’ target RNA but not a bla target sequence (Figure 6A). Similarly,
the crRNA designed against the 5’ region of the bla mRNA directed cleavage of the bla
target sequence but not the X’ target RNA (Figure 6A). The cleavage product sizes are
consistent with target cleavage 14 nt from the 5’ ends of the crRNAs. The 5’ bla crRNA and
a crRNA designed against an internal region of the bla mRNA were also tested for the
ability to direct cleavage in the context of the full-length bla mRNA. The 5’ radiolabeled bla
mRNA (~860 nt) was cleaved by Cmr complexes reconstituted with both bla crRNAs,
yielding products of the expected sizes (~17 nt for the 5’ bla crRNA and ~236 nt for the
internal bla crRNA) (Figure 6B). These results demonstrate that the Cmr complex can be
directed to cleave novel target RNAs at a desired site by crRNAs designed with an
appropriate repeat tag sequence and a guide region complementary to the target cleavage
site.
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DISCUSSION
The RNA targeting branch of the CRISPR-Cas immune system
There is tremendous diversity in the CRISPR-Cas immune pathways that protect
prokaryotes from invaders (recently reviewed in: (Deveau et al., 2010; Garrett et al., 2011;
Horvath and Barrangou, 2010; Jore et al., 2011a; Karginov and Hannon, 2010; Makarova et
al., 2011; Marraffini and Sontheimer, 2010; Terns and Terns, 2011; van der Oost et al.,
2009)). The different CRISPR-Cas systems are populated by distinct modules of proteins,
and the mechanisms of key steps in the pathways, including crRNA biogenesis and invader
silencing, can be fundamentally different. In this work, we investigated the Cmr effector
complex, which is unique among systems characterized to date in that it targets RNAs rather
than DNAs (Hale et al., 2009). This RNA-targeting branch of the CRISPR-Cas immune
system appears to play an important role in the war against viruses and other mobile genetic
elements given that approximately 70% of the archaea and 30% of the bacteria with
CRISPR-Cas systems include the Cmr module (Shah and Garrett, 2011). Our results provide
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direct evidence that the CRISPR-Cmr system cleaves complementary RNAs in vivo (Figure
4). Moreover, we have identified the key structural features of the crRNAs associated with
active Cmr complexes (Figures 1-3, 5) and engineered crRNAs capable of directing Cmr
complexes to efficiently cleave selected RNA targets at predictable sites (Figure 6).
Anatomy of the Cmr complex guide RNAs
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The crRNAs associated with the Cmr complex are of two sizes, 39 and 45 nt in length, both
with an 8-nt CRISPR repeat sequence at the 5’ end (5’ tag) followed by either 31 or 39 nt of
invader guide sequence (Figures 1 and 3, and (Hale et al., 2009)). Unlike other crRNAs
found in P. furiosus, the Cmr crRNAs contain little or no CRISPR repeat sequence at the 3’
end (Figure 3). Our studies revealed that the crRNAs present in Cmr complexes are
essentially restricted to an absolute length of 39 or 45 nt, which may be defined by a
mechanism that measures from the 5’ end of the crRNA or from the 5’ tag sequence, but
does not depend on the position of the guide sequence-3’ repeat sequence boundary (Figure
3). Both the 39- and 45-nt crRNAs have 5’ hydroxyl and 3’ phosphate end groups (Figure
1D). Overall, the 39- and 45-nt forms are found in roughly equal proportion in the purified
Cmr complexes (Figure 3A); however, the proportion of the two forms for an individual
crRNA can vary significantly (see crRNAs 4.01 and 4.05, Figure 3B), and the basis for this
variation is unclear. It is not yet known whether individual Cmr complexes contain one or
more crRNAs, however, functional Cmr complexes can be reconstituted with either the 39or 45-nt crRNA species, indicating that both forms are not simultaneously required for
cleavage activity and hinting that each Cmr complex may harbor a single crRNA.

NIH-PA Author Manuscript

While the 5’ ends of the Cmr complex crRNAs are presumably generated by cleavage of
CRISPR transcripts by the site-specific riboendonuclease Cas6 (Carte et al., 2010; Carte et
al., 2008; Wang et al., 2011), we do not yet know how the 3’ ends of mature crRNAs are
generated or how the 39- and 45-nt crRNAs are selectively incorporated into Cmr
complexes. This exquisite selectivity may simply be because the Cmr complex proteins
preferentially bind crRNAs of these lengths. Alternatively, the proteins may associate with
longer crRNA species (e.g., the 1X intermediate generated by Cas6 cleavage that includes
an additional 22 nt of the repeat at the 3’ end) and the 3’ ends may be generated following
formation of the complexes. The nuclease(s) responsible for crRNA 3’ end trimming could
be an intrinsic subunit of the Cmr complex or an extrinsic enzyme that may or may not be
specific for crRNA processing. The precisely measured 3’ ends of the Cmr complex crRNAs
could result, for example, from a combination of non-specific nuclease activity and specific
RNA protection by Cmr proteins. The 45-nt crRNA and the other crRNA size forms found
in P. furiosus (which contain longer 3’ ends; see Figures 1 and 3A) are components of other
RNP complexes currently under investigation ((Hale et al., 2008), and our unpublished
data). The P. furiosus genome encodes 21 Cas proteins in addition to the 6 Cmr proteins,
including Csa and Cst subtype proteins that are also expected to associate with crRNAs to
form additional effector complexes. Future work will elucidate the mechanisms by which
distinct crRNA species are sorted among CRISPR-Cas complexes within a cell.
The 5’ tag is critical for Cmr complex crRNA function
The results presented here indicate that the 5’ tag sequence is necessary for crRNA function
in Cmr complexes (Figure 5). We found that the sequence, and perhaps size, of the 5’ tag is
important for Cmr complex crRNA function; even subtle mutations are detrimental to Cmr
activity. We hypothesize that the 5’ tag is important as a binding site for one or more Cmr
proteins. Consistent with this idea, we found that crRNAs from CRISPR locus 8 with variant
5’ repeat tags are preferentially excluded from Cmr complexes in vivo (Figure 5C). As
discussed above, the basis for exclusion of longer crRNA species, which possess the 5’ tag,
from Cmr complexes in P. furiosus is not yet clear. The presence of a 5’ tag sequence is a
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conserved feature of crRNAs in many CRISPR-Cas systems (Brouns et al., 2008; Hale et al.,
2008; Hale et al., 2009; Haurwitz et al., 2010; Lintner et al., 2011; Marraffini and
Sontheimer, 2008). A correlation exists between specific CRISPR-Cas modules and the
CRISPR repeat sequences found together in various organisms, suggesting that the different
systems may recognize characteristic 5’ tags. However, in P. furiosus the crRNAs encoded
by the 7 CRISPR loci generally share the same 5’ tag sequence, which evidently functions
with the Csa and Cst as well as Cmr modules. We hypothesize that the 5’ tag is also
important in effector complex function in the other systems where it is found. Our results
reveal the functional importance of the 5’ tag in Cmr effector complex function.
Directing Cmr complexes to cleave RNAs of choice
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In this work, we have demonstrated that crRNAs can be designed to target the Cmr complex
to cleave novel RNA substrates (Figure 6). crRNAs comprised of a 37-nt complementary
guide sequence and 5’-tag were used to direct specific cleavage of RNAs including the βlactamase mRNA in vitro. Cleavage product sizes indicate that the target was predictably cut
14 nt downstream of the 3’ end of the engineered crRNA. These findings will enable efforts
to exploit the site-specific cleavage function of Cmr-crRNA complexes for in vivo gene
knockdown experiments. Our studies have defined the minimal components for Cmr
complex function (Cmr1-6 and a crRNA; Figure 6 and (Hale et al., 2009)), making it
conceivable to express functional Cmr complexes in eukaryotes as well as additional
prokaryotes to provide a novel method of RNA silencing. Our results indicate that CmrcrRNA complexes have the potential to target destruction of mRNAs encoding any gene of
interest and to become important research tools with industrial and biomedical applications.
RNA targeting vs. DNA targeting CRISPR-based gene silencing systems
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Our findings demonstrate that there are significant differences in the modes of target nucleic
acid recognition for CRISPR-based gene silencing systems that target RNA and DNA. For
example, while DNA targeting by at least some CRISPR-Cas systems requires a short PAM
(protospacer adjacent motif) in the invading DNA target (Deveau et al., 2008; Garneau et
al., 2010; Gudbergsdottir et al., 2011; Mojica et al., 2009; Semenova et al., 2011), our work
suggests that Cmr complexes function independently of PAMs. Cmr-crRNA complexes can
cleave target RNAs that completely lack flanking sequences or contain a variety of flanking
sequences (that do not match predicted PAMs; Figures 1, 4, and 6 and (Hale et al., 2009)).
For DNA-targeting systems, the requirement for a PAM sequence in the invader avoids
damage to the host genome at the site of the corresponding guide sequence in the CRISPR
locus (where PAMs are not found in the flanking repeat sequences). The DNA-targeting
system of Staphylococcus epidermidis further demonstrates an explicit requirement for
mismatches between the 5’ tag of the crRNA and the target DNA strand, which also
prevents targeting the host CRISPR locus (Marraffini and Sontheimer, 2010). In contrast, for
the RNA-targeting Cmr complex (where host genome damage is not a risk) target RNAs
containing sequences with perfect homology to the 5’ tag of the crRNA are efficiently
cleaved (Figures 4 and 5D). Evidence indicates that there are also differences in the
interactions with the guide region of the crRNA. A specific 7-8 nt region of the crRNA
located immediately downstream of the 5’ tag (dubbed the “seed sequence”) was found to be
important for initial high affinity recognition of targets for certain DNA-targeting CRISPRCas systems (Semenova et al., 2011; Wiedenheft et al., 2011). Base-pairing between the 3’
end of the crRNA and target DNA was dramatically less important. The opposite trend is
observed for RNA targeting, where interaction with the 3’ end of the crRNA is critical for
function and target RNAs that lack the “seed sequence” region are efficiently cleaved (Hale
et al., 2009). The molecular bases of these differences in CRISPR-Cas RNA and DNA
targeting pathways remain to be explored. The lack of restrictions in the flanking sequence
content in RNA targeting provides for more flexibility in substrate interaction.
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EXPERIMENTAL PROCEDURES
Antibody preparation and co-immunoprecipitation reactions
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IgY antibodies were raised against recombinant P. furiosus Cmr2 as described (Carte et al.,
2010). Pre-immune and immune Cmr2 antibodies were either coupled to anti-IgY
conjugated agarose beads (Gallus Immunotech) for Northern analysis, end analysis or small
RNA sequencing, or to CarboLink beads (Pierce) for Western analysis.
Co-IP/Western analysis
Western blotting of co-IP material was performed by standard procedures.
Co-IP/Northern analysis
Trizol LS reagent (Invitrogen) was used to isolate RNAs from the co-IP samples and P.
furiosus extract (total RNA). Northern analysis was performed as described previously (Hale
et al., 2008) with modifications (see Supplemental Experimental Procedures). Probe
sequences can be found in Supplemental Table 1.
Co-IP/Activity assays
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Co-IP beads were washed into 40 mM Hepes pH 7.0, 500 mM KCl and added to a 20 μl
cleavage reaction containing radiolabeled target RNA (5,000 cpm). Reactions were
incubated for 3 hours at 70°C with mixing. RNAs were isolated by proteinase K treatment,
phenol extraction and ethanol precipitation and separated on 7M urea 15% polyacrylamide
gels and visualized by phosphor imaging.
Co-IP/End analysis
Trizol LS was used to isolate small RNAs from co-IP samples. The RNAs were treated with
thermostable shrimp alkaline phosphatase (Promega). Treated and non-treated RNAs was
subject to either: 1) 5’ radiolabeling with γ32P-ATP (MP Biomedicals) via polynucleotide
kinase (Ambion), or 2) 3’ radiolabeling via T4 ssRNA Ligase 1 (NEB) with cytidine-3’,5’bisphosphate [5’-32P] (3,000 ci/mmol, MP Biomedicals). Both labeling reactions were
carried out for 1 hour at 37°C and the RNAs were isolated, separated by denaturing gel
electrophoresis, and visualized by phosphor imaging.
Small RNA library preparation
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For preparation of total and Cmr-associated small RNA libraries, Trizol was used to extract
RNAs from P. furiosus cells or from a co-IP reaction, respectively. 50 μg of total RNA was
used for total small RNA library preparation. Briefly, the RNAs were phosphatase treated to
remove 3’ phosphates, followed by 3’ ligation to an adaptor. These products were treated
with T4 polynucleotide kinase before 5’ ligation to an additional adaptor. The 5’ and 3’
ligated products were subject to reverse transcription, RNase H digestion and PCR.
Illumina sequencing and analysis
cDNA libraries were visualized by electrophoresis, quantitated by Agilent Bioanalyzer and
Nano-drop, diluted to 2 pM, and subject to 76 cycles of sequencing on the Illumina Genome
Analyzer IIx. Sequence reads were trimmed of the 3’ linker and reads 18-76 nt in length
were aligned to the P. furiosus genome using Bowtie (Langmead et al., 2009). The 5’ and 3’
ends of reads mapping to the CRISPR loci were calculated using a custom PERL script
available upon request.
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Recombinant Cmr protein production and activity assays
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Expression and purification of recombinant Cmr proteins was performed as described (Hale
et al., 2009) with modifications (See Supplemental Experimental Procedures). RNA
cleavage assays were performed as described (Hale et al., 2009). Briefly, all six recombinant
Cmr proteins (500 nM each) were pre-incubated with unlabeled crRNA (0.05 pmol) prior to
addition of 5’ radiolabeled target RNAs (5,000 cpm). Reactions were incubated for 1-3
hours at 70°C and isolated RNAs analyzed by denaturing gel electrophoresis and phosphor
imaging.
RNA preparation
Sequences of RNA/DNA oligos used for RNA preparation are found in Supplemental Table
1, and detailed information about RNA preparation is found in the Supplemental
Experimental Procedures.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cmr2 antibodies immunopurify active Cmr-crRNA complexes
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A) Cmr2 antibodies recognize and specifically immunoprecipitate ~100 kD protein. P.
furiosus S100 extract (T) and PfCmr2 antibody immune (I) and pre-immune (PI)
immunoprecipitation (IP) samples were analyzed by Western blotting with Cmr2 antibodies.
Positions of size markers are indicated. ~100 kD protein specifically recognized by
immunoblotting and immunoprecipitated by Cmr2 antibodies is indicated by arrow. B) 45and 39-nt crRNAs are immunopurified with Cmr2 antibodies. RNAs extracted from P.
furiosus S100 extract (T) and immune (I) and pre-immune (PI) immunoprecipitation (IP)
samples were analyzed by Northern blotting with a probe against P. furiosus crRNA 7.01.
The 45- and 39-nt species of 7.01 that are co-IPed with the Cmr2 antibodies are indicated by
arrows. Sizes of RNA markers (M) are shown. C) Immunoprecipitated Cmr complexes
cleave a target RNA. 5’ end-labeled 7.01 target RNA (complementary to crRNA 7.01,
indicated with arrow) was incubated in the absence (−) of proteins or in the presence of
immune (I) and pre-immune (PI) immunoprecipitation samples. Cleavage products are
marked with asterisks. D) Co-immunopurified crRNAs possess 5’ OH and 3’ phosphate
ends. Immunoprecipitated crRNAs were isolated and 5’ or 3’ labeled with (+) and without
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(−) prior phosphatase treatment. The 45- and 39-nt crRNA species are indicated by arrows
and RNA size markers (M) are shown.
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Figure 2. Deep sequencing profiles of crRNAs found in total P. furiosus RNA and
immunopurified Cmr complexes

A) Total and Cmr-associated small RNA sequencing reads that map to the seven P. furiosus
CRISPR loci. Y-axis scale bars indicate the number of reads (thousands) that contain
nucleotides that map to the indicated position within the CRISPR locus. Red indicates
sequence reads that map to the sense strand relative to the CRISPR leader region, and blue
corresponds to reads that map to the antisense strand. The positions of CRISPR repeats are
shown as black bars below the graph. 1 kb x-axis scale is indicated. Images were generated
using the UCSC archaeal genome browser (Karolchik et al., 2003). B) Putative promoter
sequences found in the P. furiosus CRISPR leader regions. Alignment of the regions
upstream of the first repeat of each P. furiosus CRISPR locus are shown. The repeats are
shown in blue, the initial transcribed regions (detected by sequencing) are shown in red, the
potential TATA elements are shown in pink, the potential BRE elements are underlined, and
other leader sequences are shown in black. Consensus BRE/TATA elements are shown
above the alignment.
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Figure 3. Cmr complex crRNAs contain a conserved 8-nucleotide 5’ sequence tag and are of
defined 39- and 45-nucleotide lengths
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A) The 5’ and 3’ ends of Cmr-associated crRNAs are defined relative to the upstream repeat
element. Graphs show the % of crRNAs sequenced in total P. furiosus RNA (upper panel)
and immunopurified Cmr complexes (lower) with ends that map at indicated positions
relative to the 5’ repeat-guide junction (arrowhead). The Cmr-associated crRNA species are
illustrated below with 5’ repeat tag (black) and guide sequence (green) indicated. RNAs
from CRISPR8 were excluded from this analysis due to a repeat sequence polymorphism
(see text). Read numbers analyzed (n) are indicated. B) The length of the Cmr complex
crRNAs is independent of the length of the genome-encoded guide sequence. Deep sequence
profiles of crRNAs 4.01 – 4.05 in total P. furiosus RNA (upper panel) and immunopurified
Cmr complexes (lower) are shown relative to repeat (black) and guide (green) sequence
elements (see also Figure 2A). Dashed lines mark the 3’ ends of the 45-nucleotide crRNA
species. (The 5’ end and 3’ end of the 39-nucleotide species are also indicated for crRNA
4.01.) The sequence at the 3’ guide-repeat junction is shown below for crRNAs 4.01, 4.02
and 4.05. Guide sequences are shown in green, and repeat sequences are shown in black.
Arrowheads indicate the locations of the 3’ ends of the 45-nucleotide crRNA species.
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Figure 4. Antisense RNA found in P. furiosus is cleaved by the Cmr-crRNA complex
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A) Antisense RNA from the region of crRNA 1.01 is detected by Northern analysis, and two
species are associated with the Cmr complex. Northern analysis of total P. furiosus RNA (T)
and RNAs isolated from immune (I) or pre-immune (PI) Cmr2 immunopurifications was
probed for antisense (left panel) or sense 1.01 crRNAs (right panel). Colored dots indicate
the primary species of antisense RNAs (blue dots) and crRNAs (red dots) specifically
associated with the Cmr complex (and correspond with dots in panel B). Sizes of
radiolabeled RNA marker (M) are noted. B) The two antisense RNAs associated with the
Cmr complex map downstream of a potential fortuitous promoter and correspond to the
expected products of crRNA 1.01-guided cleavage. Deep sequencing profiles of Cmrassociated crRNAs in the region encoding crRNA 1.01 are shown. Red indicates RNAs
transcribed from the leader region, and blue corresponds to reads from the opposite strand.
The positions of CRISPR repeats (black), guide sequences (green) and BRE/TATA
promoters (red and blue) are indicated. A blue line represents the apparent full-length
antisense RNA observed by deep sequencing total RNA (see Figure S1). Cleavage of the
antisense RNA by the Cmr complex 14 nucleotides from the 3’ ends of the 45- and 39-nt
species of crRNA 1.01 (red dots) would produce antisense RNA products of the sizes
observed by deep sequencing and Northern analysis (blue dots). C) Immunopurified Cmr
complexes cleave the antisense RNA. Radiolabeled RNA targets for the antisense RNAs (left
panel) and crRNAs (right panel) were incubated in the absence (−) of proteins or in the
presence of immune (I) or pre-immune (PI) immunourified preparations, and the products
were analyzed following denaturing gel electrophoresis. (The target for the crRNAs is 140
nucleotides in length and corresponds to the full-length antisense RNA (see panel C).) The

Mol Cell. Author manuscript; available in PMC 2013 February 10.

Hale et al.

Page 18

NIH-PA Author Manuscript

cleavage products obtained by incubation of the crRNA target with the immunopurified Cmr
complex (asterisks) are approximately the same sizes as the endogenous antisense RNA
species that are immunopurified with the Cmr complexes (A, left panel). Non-contiguous
lanes from the same gel are indicated by dashed lines.
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Figure 5. The 5’ repeat tag is required for formation of functional Cmr complexes
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A) The 5’ repeat tag is required for Cmr complex function. Reconstitutions were performed
with recombinant Cmr1-6 proteins and the 45-nt. wildtype 7.01 crRNA (AUUGAAAG tag)
or crRNA 7.01 lacking the tag (−), and activity was tested against the radiolabeled 7.01
target RNA. RNA marker sizes are indicated. The cleavage product observed with the
wildtype crRNA is indicated with an asterisk. B) Mutations to the tag sequence prevent
function. Reconstitutions were performed with the 45-nucleotide wildtype 7.01 crRNA
(AUUGAAAG tag) or crRNA 7.01 with the indicated mutations in the tag sequence
(mutated or inserted nucleotides are highlighted in red) and tested in cleavage assays as
described in A. The cleavage product observed with the wildtype crRNA is indicated with
an asterisk. C) crRNAs with variant tag sequences are underrepresented in the Cmr
complex. Deep sequencing profiles of Cmr-associated crRNAs in the region encoding
crRNAs 8.08 – 8.11 are shown (see also Figure 2A). The positions of CRISPR repeats
(black) and guide sequences (green) are indicated. The 5’ tag sequence is shown below for
crRNAs 8.08 - 8.11. An additional nucleotide present in the wildtype tag of crRNA 8.11 is
highlighted in red D) Complementarity to the tag does not prevent function. Cmr complexes
reconstituted with wildtype crRNA 7.01 were tested for the ability to cleave the 7.01 target
RNA or a target with complementarity to the tag sequence (as illustrated). Cleavage
products are indicated with asterisks. Non-contiguous lanes from the same gel are indicated
with a dashed line.
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Figure 6. Engineered crRNAs direct the Cmr complex to cleave intended target RNAs
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A) Specific cleavage of novel target RNAs. Cmr complexes were reconstituted with crRNAs
designed to target a random sequence (X crRNA, X’ target, orange) or a fragment from the
5’ end of the β-lactamase (bla) mRNA (5’ bla crRNA, bla target, red), and tested for the
ability to cleave both target RNAs. Cleavage products are indicated with asterisks. Diagrams
illustrate engineered crRNAs with 5’ repeat tag (black) and guide sequence elements
(orange or red) interacting with and cleaving the intended 5’ radiolabeled target. B) Directed
cleavage of predicted sites in β-lactamase mRNA. Engineered crRNAs target two locations
on the full-length bla mRNA. The full length bla mRNA was subject to cleavage by Cmr
complexes reconstituted with crRNAs targeting a region near the 5’ end of the mRNA (5’
bla crRNA, red) or a sequence approximately 200 nucleotides from the 5’ end of the mRNA
(internal bla crRNA, blue). Cleavage products are indicated by asterisks. Diagrams illustrate
engineered crRNAs interacting with and cleaving the bla mRNA.
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